Your browser doesn't support javascript.
loading
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort.
Russell, Lucy L; Greaves, Caroline V; Bocchetta, Martina; Nicholas, Jennifer; Convery, Rhian S; Moore, Katrina; Cash, David M; van Swieten, John; Jiskoot, Lize; Moreno, Fermin; Sanchez-Valle, Raquel; Borroni, Barbara; Laforce, Robert; Masellis, Mario; Tartaglia, Maria Carmela; Graff, Caroline; Rotondo, Emanuela; Galimberti, Daniela; Rowe, James B; Finger, Elizabeth; Synofzik, Matthis; Vandenberghe, Rik; de Mendonça, Alexandre; Tagliavini, Fabrizio; Santana, Isabel; Ducharme, Simon; Butler, Chris; Gerhard, Alex; Levin, Johannes; Danek, Adrian; Otto, Markus; Warren, Jason D; Rohrer, Jonathan D.
Affiliation
  • Russell LL; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Greaves CV; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Nicholas J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK; Institute of Prion Disease, UCL Queen Square Institute of Neurology, London, UK.
  • Convery RS; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Moore K; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Cash DM; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • van Swieten J; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
  • Jiskoot L; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
  • Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.
  • Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain.
  • Borroni B; Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques du CHU de Québec, Université Laval, Québec, Canada.
  • Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
  • Graff C; Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.
  • Rotondo E; University of Milan, Centro Dino Ferrari, Milan, Italy.
  • Galimberti D; University of Milan, Centro Dino Ferrari, Milan, Italy; Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.
  • Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
  • Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
  • Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
  • de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
  • Tagliavini F; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologica Carlo Besta, Milano, Italy.
  • Santana I; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Ducharme S; Department of Psychiatry, McGill University, Montreal, Québec, Canada.
  • Butler C; Department of Clinical Neurology, University of Oxford, Oxford, UK.
  • Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg- Essen, Germany.
  • Levin J; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
  • Danek A; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
  • Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
  • Warren JD; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK.
  • Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, London, UK. Electronic address: j.rohrer@ucl.ac.uk.
Cortex ; 133: 384-398, 2020 12.
Article in En | MEDLINE | ID: mdl-33221702
ABSTRACT
A key symptom of frontotemporal dementia (FTD) is difficulty interacting socially with others. Social cognition problems in FTD include impaired emotion processing and theory of mind difficulties, and whilst these have been studied extensively in sporadic FTD, few studies have investigated them in familial FTD. Facial Emotion Recognition (FER) and Faux Pas (FP) recognition tests were used to study social cognition within the Genetic Frontotemporal Dementia Initiative (GENFI), a large familial FTD cohort of C9orf72, GRN, and MAPT mutation carriers. 627 participants undertook at least one of the tasks, and were separated into mutation-negative healthy controls, presymptomatic mutation carriers (split into early and late groups) and symptomatic mutation carriers. Groups were compared using a linear regression model with bootstrapping, adjusting for age, sex, education, and for the FP recognition test, language. Neural correlates of social cognition deficits were explored using a voxel-based morphometry (VBM) study. All three of the symptomatic genetic groups were impaired on both tasks with no significant difference between them. However, prior to onset, only the late presymptomatic C9orf72 mutation carriers on the FER test were impaired compared to the control group, with a subanalysis showing differences particularly in fear and sadness. The VBM analysis revealed that impaired social cognition was mainly associated with a left hemisphere predominant network of regions involving particularly the striatum, orbitofrontal cortex and insula, and to a lesser extent the inferomedial temporal lobe and other areas of the frontal lobe. In conclusion, theory of mind and emotion processing abilities are impaired in familial FTD, with early changes occurring prior to symptom onset in C9orf72 presymptomatic mutation carriers. Future work should investigate how performance changes over time, in order to gain a clearer insight into social cognitive impairment over the course of the disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Frontotemporal Dementia Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cortex Year: 2020 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Frontotemporal Dementia Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cortex Year: 2020 Document type: Article Affiliation country: United kingdom
...